These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 20179353)
1. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. Labadie K; Larcher T; Joubert C; Mannioui A; Delache B; Brochard P; Guigand L; Dubreil L; Lebon P; Verrier B; de Lamballerie X; Suhrbier A; Cherel Y; Le Grand R; Roques P J Clin Invest; 2010 Mar; 120(3):894-906. PubMed ID: 20179353 [TBL] [Abstract][Full Text] [Related]
2. A nonhuman primate model of chikungunya disease. Higgs S; Ziegler SA J Clin Invest; 2010 Mar; 120(3):657-60. PubMed ID: 20179348 [TBL] [Abstract][Full Text] [Related]
3. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. Hawman DW; Stoermer KA; Montgomery SA; Pal P; Oko L; Diamond MS; Morrison TE J Virol; 2013 Dec; 87(24):13878-88. PubMed ID: 24131709 [TBL] [Abstract][Full Text] [Related]
4. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity. Messaoudi I; Vomaske J; Totonchy T; Kreklywich CN; Haberthur K; Springgay L; Brien JD; Diamond MS; Defilippis VR; Streblow DN PLoS Negl Trop Dis; 2013; 7(7):e2343. PubMed ID: 23936572 [TBL] [Abstract][Full Text] [Related]
5. Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody. Hong JP; McCarthy MK; Davenport BJ; Morrison TE; Diamond MS J Virol; 2019 Dec; 93(24):. PubMed ID: 31578287 [TBL] [Abstract][Full Text] [Related]
6. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. Couderc T; Chrétien F; Schilte C; Disson O; Brigitte M; Guivel-Benhassine F; Touret Y; Barau G; Cayet N; Schuffenecker I; Desprès P; Arenzana-Seisdedos F; Michault A; Albert ML; Lecuit M PLoS Pathog; 2008 Feb; 4(2):e29. PubMed ID: 18282093 [TBL] [Abstract][Full Text] [Related]
7. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. Mallilankaraman K; Shedlock DJ; Bao H; Kawalekar OU; Fagone P; Ramanathan AA; Ferraro B; Stabenow J; Vijayachari P; Sundaram SG; Muruganandam N; Sarangan G; Srikanth P; Khan AS; Lewis MG; Kim JJ; Sardesai NY; Muthumani K; Weiner DB PLoS Negl Trop Dis; 2011 Jan; 5(1):e928. PubMed ID: 21264351 [TBL] [Abstract][Full Text] [Related]
8. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. Teo TH; Her Z; Tan JJ; Lum FM; Lee WW; Chan YH; Ong RY; Kam YW; Leparc-Goffart I; Gallian P; Rénia L; de Lamballerie X; Ng LF J Virol; 2015 Aug; 89(15):7955-69. PubMed ID: 25995257 [TBL] [Abstract][Full Text] [Related]
10. Chikungunya antibodies detected in non-human primates and rats in three Indian Ocean islands after the 2006 ChikV outbreak. Vourc'h G; Halos L; Desvars A; Boué F; Pascal M; Lecollinet S; Zientara S; Duval T; Nzonza A; Brémont M Vet Res; 2014 May; 45(1):52. PubMed ID: 24885529 [TBL] [Abstract][Full Text] [Related]
11. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Morrison TE; Oko L; Montgomery SA; Whitmore AC; Lotstein AR; Gunn BM; Elmore SA; Heise MT Am J Pathol; 2011 Jan; 178(1):32-40. PubMed ID: 21224040 [TBL] [Abstract][Full Text] [Related]
12. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. Dupuis-Maguiraga L; Noret M; Brun S; Le Grand R; Gras G; Roques P PLoS Negl Trop Dis; 2012; 6(3):e1446. PubMed ID: 22479654 [TBL] [Abstract][Full Text] [Related]
13. Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus. Rohatgi A; Corbo JC; Monte K; Higgs S; Vanlandingham DL; Kardon G; Lenschow DJ J Virol; 2014 Mar; 88(5):2414-25. PubMed ID: 24335291 [TBL] [Abstract][Full Text] [Related]
17. Immunopathology of Chikungunya Virus Infection: Lessons Learned from Patients and Animal Models. Ng LFP Annu Rev Virol; 2017 Sep; 4(1):413-427. PubMed ID: 28637387 [TBL] [Abstract][Full Text] [Related]
18. A mouse model of chikungunya virus with utility in antiviral studies. Dagley A; Julander JG Methods Mol Biol; 2013; 1030():439-48. PubMed ID: 23821287 [TBL] [Abstract][Full Text] [Related]
19. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity. Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771 [TBL] [Abstract][Full Text] [Related]
20. Chikungunya and the nervous system: what we do and do not know. Arpino C; Curatolo P; Rezza G Rev Med Virol; 2009 May; 19(3):121-9. PubMed ID: 19274635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]